Estrogen-Containing Oral Contraceptive Preparations (30 Mcg Ethinylestradiol And 150 Mcg Levonorgestrel) has 2 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Lamotrigine, Lamotrigine Extended-Release. Patients taking Estrogen-Containing Oral Contraceptive Preparations (30 Mcg Ethinylestradiol And 150 Mcg Levonorgestrel) should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Moderate
- 2
Moderate (2)
- Estrogen-Containing Oral Contraceptive Preparations (30 Mcg Ethinylestradiol And 150 Mcg Levonorgestrel) + Lamotrigine— Decreased lamotrigine concentrations approximately 50%. Decrease in levonorgestrel component by 19%.
- Estrogen-Containing Oral Contraceptive Preparations (30 Mcg Ethinylestradiol And 150 Mcg Levonorgestrel) + Lamotrigine Extended-Release— Decreases lamotrigine concentrations approximately 50%. Decreases levonorgestrel component by 19%.